Enterprise record
NEONC TECHNOLOGIES HOLDINGS, INC.
Public governance Claims and source records for this enterprise.
Follow
More
Alpha ID: alpha:company:0e27ca4d-89e8-440f-b379-f50da2b935b2Version: public-1As of: unavailable
15 published Claims2 sources
Key Claims
Board and committees
Evidence, history and coverage
Additional published Claims
Published evidence records
2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Sep 28, 2026
Supports 3 claims
- Legal Name: NEONC TECHNOLOGIES HOLDINGS, INC. · Claim reviewed: Sep 28, 2026
- Entity Status: Public listing published · Claim reviewed: Sep 28, 2026
- Published Fact: US · Claim reviewed: Sep 28, 2026
SEC DEF 14A 0001829126-26-006775
sec def 14a · Source published: Jun 23, 2026 · Retrieved: Sep 12, 2026
Supports 12 claims
- Leadership Role: Amir Heshmatpour: Chief Executive Officer, President, Executive Chairman · Claim reviewed: Sep 28, 2026
- Leadership Role: Bader Almonawer: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Jim Delshad: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Ming-Fu (Alan) Chiang, M.D., Ph.D., MBA: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Steven L. Giannotta, M.D.: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Thomas C. Chen, M.D., Ph.D.: Chief Medical Officer, Chief Scientific Officer, Vice-chairman · Claim reviewed: Sep 28, 2026
- Leadership Role: Victoria Medvec, Ph.D.: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Amir Heshmatpour: Chief Executive Officer and President · Claim reviewed: Sep 28, 2026
- Leadership Role: David Suh: Chief Accounting Officer · Claim reviewed: Sep 28, 2026
- Leadership Role: Josh Neman, Ph.D.: Chief Clinical Officer · Claim reviewed: Sep 28, 2026
- Leadership Role: Keithly Garnett: Chief Financial Officer · Claim reviewed: Sep 28, 2026
- Leadership Role: Thomas C. Chen, M.D., Ph.D.: Chief Medical Officer and Chief Scientific Officer · Claim reviewed: Sep 28, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-28
- Board and committees
- published
- Control and shareholders
- not observed
- Compensation
- not observed
- Auditors, advisors and reporting
- not observed
- Legal
- not observed
- AI governance
- not observed

